Presenting CataloniaBio & HealthTech Blog Post

A new era for the CataloniaBio association of companies and the HealthTech Cluster. Members of the two organisations unanimously passed the motion to merge under the brand CataloniaBio & HealthTech at their respective extraordinary general meetings held in Barcelona yesterday.The headquarters will be located at the Barcelona Science Park. It will promote the convergence of biopharma, MedTech and digital health companies to boost competitiveness and address unmet medical needs 

 

Cebiotex launches a €650,000 crowdfunding campaign to ensure that its oncological treatment reaches paediatrics Blog Post

Cebiotex—with headquarters in the Barcelona Science Park (PCB)—has launched an equity crowdfunding campaign of €650,000 through Capital Cell to ensure that its first drug, CEB-01, used in the local post-surgical treatment of soft tissue sarcomas, also reaches paediatric oncology. CEB-01 is the first therapeutic application of its innovative technology, which are based on nanofibres, for local drug delivery. In the future, however, the company aims to develop new applications for pancreatic and liver cancer, as well as glioblastoma.Since it was formed in 2012, Cebiotex has raised over €2 million from public and private funds. The success of the previous equity crowdfunding campaigns and the participation of impactful social investors has allowed Cebiotex to maintain a paediatric focus as one of the company’s strategic objectives.

 

Cells sense their environment to explore it Blog Post

The way cells find their way around is by ‘groping’ rather than seeing their surroundings: this is the main conclusion of a study published in Nature last week involving several IBEC groups and their collaborators. The study was led by Pere Roca-Cusachs, lecturer from the Department of Biomedicine and main researcher at the Institute for Bioengineering of Catalonia (IBEC) at the Barcelona Science Park (PCB).

 

A genetic mutation in the evolution of animals explains the origin of some human organs Blog Post

A neutral genetic mutation –a fluke in the evolutionary process with no apparent biological purpose– that appeared over 700 million years ago in biological evolution could help explain the origin of complex organs and structures in human beings and other vertebrates, according to an article published in Nature Communications by a team led by Professor Jordi García-Fernàndez, from the Faculty of Biology of the University of Barcelona (UB) and the Institute of Biomedicine of the UB (IBUB) at the Barcelona Science Park (PCB), Manuel Irimia (CRG) and Maria Ina Arnone (Anton Dohrn Zoological Station, Italy).

 

Genesis Biomed presents its new Genesis Ventures fund Blog Post

Today Genesis Biomed has presented at the Barcelona Science Park a new investment fund, Genesis Ventures, made up of various family offices that are looking to invest in research and business projects in the very early stages in the field of biomedicine. With this initiative, the company based at PCB, wants to help entrepreneurs put together the capital they need for their research in order to later attract series-A corporate funds or venture capital.

 

Mind the Byte and Prosilico sign a strategic partnership agreement Blog Post

Mind the Byte, located at the Barcelona Science Park (PCB) and at Copenhagen BioScience Park (COBIS), announces that it has just signed an agreement to share technology with the Swedish-based company Prosilico. This agreement fits with the Catalan bioinformatics company’s plans to expand internationally through strategic alliances and increase its range of services.

 

Bioengineering for Healthy Ageing Blog Post

Under the theme of “Bioengineering for Healthy Ageing. Adding Life to Years”, more than 75 international scientists, clinicians and other experts met yesterday at CosmoCaixa Barcelona in an event hosted by B·Debate, an initiative of Biocat and the “la Caixa” Foundation. In this edition, the Institute for Bioengineering of Catalonia (IBEC) –based at the Barcelona Science Park– led the event that brougth together world-renowned researchers to examine possible solutions bioengineering can provide to address the challenges an ageing population faces.

 

Entities from PCB promote their international presence at BIO-Europe 2017 Blog Post

From 6 to 8 November, Belin will host BIO-Europe 2017, the largest partnering gathering of the biotech and pharmaceutical industry in Europe and one of the largest in the world. The event, organized by EBD-Group with the collaboration of Biocat –based at the Barcelona Science Park (PCB)– will again draw over 3,800 industry attendees from over 60 countries, representing more than 2,000 companies and It will have a important representation of PCB.

 

Esteve closes the Board of Directors renewal process with the appointment of Joan Esteve as a Chairman Blog Post

Esteve has just announced changes to its corporate governing bodies. In line with the plan approved by the Group’s Board, Albert Esteve will replace Joan Esteve as Chairman of the Board and announces the appointment of Staffan Schüberg, executive vicepresident of the Danish pharmaceutical company Lundbeckas, the group’s Chief Executive Officer. Since 2012, all discovery and preclinical development key units of Esteve are located at the Barcelona Science Park with the latest infrastructure and technology in a top-level academic and scientific environment in Spain.